SCHEMBL7374384

SCHEMBL7374384

Cc1cc(-c2ccc(C(=O)O)cc2)c(O)cc1[C]=O

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RXRA P19793 4/20 0.45
RXRB P28702 3/20 0.45
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
HSD17B10 Q99714 1/20 0.41
RARB P10826 2/20 0.40
ALDH1A1 P00352 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
RARA P10276 1/20 0.40
RARG P13631 1/20 0.40
MAP4K4 O95819 1/20 0.40
ERN1 O75460 1/20 0.40
HSD17B1 P14061 1/20 0.40
ADH5 P11766 1/20 0.39
EGFR P00533 1/20 0.39
RXRG P48443 1/20 0.38
XDH P47989 1/20 0.38
SLC22A12 Q96S37 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7373530 0.85 LMNA (0.43) RXRARXRBKDM4ELMNAHSD17B10
SCHEMBL7370563 0.85 SRD5A2 (0.49) RXRARXRBKDM4ERARBALDH1A1
SCHEMBL7371062 0.83 BACE1 (0.52) KDM4EHSD17B10ALDH1A1EGFR
SCHEMBL7371208 0.82 RXRA (0.44) RXRARXRBLMNARARBALDH1A1
SCHEMBL7371306 0.79 KDM5A (0.43) RXRARXRBRARBALDH1A1SMN1; SMN2
SCHEMBL16749653 0.77 RXRA (0.59) RXRARXRBRARBALDH1A1SMN1; SMN2
SCHEMBL29133892 0.77 TP53 (0.57) RXRARXRBKDM4ELMNAHSD17B10
SCHEMBL22824136 0.76 RXRA (0.57) RXRARXRBRARBALDH1A1SMN1; SMN2
SCHEMBL2951077 0.74 RXRA (0.55) RXRARXRBRARBALDH1A1SMN1; SMN2
SCHEMBL4603074 0.71 GRIK1 (0.62) RXRARXRBRARBALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994021650-A1 BORONIC ACID AND ESTER INHIBITORS OF THROMBIN THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-09-29 WO disclosed